Compare
Dynamix Corp III vs Oaktree Acquisition Corp. III Life Sciences vs Pyrophyte Acquisition Corp. II vs Axiom Intelligence Acquisition Corp 1
| Latest fiscal year | Dynamix Corp III DNMX | Oaktree Acquisition Corp. III Life Sciences OACC | Pyrophyte Acquisition Corp. II PAII | Axiom Intelligence Acquisition Corp 1 AXIN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | n/a | $7.29M | n/a | n/a |
| EPS (Diluted) | n/a | n/a | n/a | n/a |
| Operating cash flow | n/a | -$422.1K | n/a | n/a |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $1.33M | $1.43M | n/a | n/a |
| Total assets | $203.94M | $203.11M | $204.80M | $205.16M |
| Total liabilities | $8.30M | $8.32M | $9.46M | $8.10M |
| Shareholders' equity | -$6.83M | -$6.77M | -$8.67M | -$7.18M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Dynamix Corp III | Oaktree Acquisition Corp. III Life Sciences | Pyrophyte Acquisition Corp. II | Axiom Intelligence Acquisition Corp 1 |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | n/a |
| 1 year earlier | n/a | n/a | n/a | n/a |
| 2 years earlier | n/a | n/a | n/a | n/a |
| 3 years earlier | n/a | n/a | n/a | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |